Abstract
The pathological appearances of chronic pancreatitis are characterised by parenchymal fibrosis, ductal stones and strictures, acinar cell atrophy and inflammatory infiltration by macrophages, neutrophils and lymphocytes. One of the key features of pancreatic fibrosis is an abundant presence of fibroblasts and an accumulation of a dense extracellular matrix which is rich in fibril-forming collagens type I and III. Deposition of extracellular matrix in a diseased pancreas must therefore be regarded as a wound-healing response, much as in fibrosis due to chronic injury in the lung, liver, kidney or joints.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bedossa P, Bacci J, Lemaigre G, Martin E (1990) Lymphocyte subsets and HLA-DR expression in normal and chronic pancreatitis. Pancreas 5:415–420.
Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039–1045.
Brunner AM et al. (1989) Site-directed mutagenesis of cysteine residues in the pro-region of the transforming growth factor beta-1 precursor. J Biol Chem 264:13660–13664.
Matrisian LM, Leroy P, Ruhlman C, Gesnel M-C, Breathnach R (1986) Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol Cell Biol 6:1679–1686.
Keski-Oja J, Raghow R, Sandey M (1988) Regulation of mRNAs for type I plasminogen activator inhibitor, fibronectin and type I procollagen by transforming growth factor-/?. J Biol Chem 263:3111–3115.
Gress T, Miiller-Pillasch F, Elsasser HP et al. (1994) Enhancement of transforming growth factor-j81 expression in the rat pancreas during regeneration from caerulin-induced pancreatitis. Eur J Clin Invest 24:679–685.
Slater SD, Williamson RC, Foster CS (1995) Expression of transforming growth factor-beta 1 in chronic pancreatitis. Digestion 56:237–241.
Sanvito F, Nichols A, Herrera PL et al. (1995) TGF-/31 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Comm 217:1279–1286.
Van Laethaem JL, Robberecht P, Resibois A, Deviere J (1996) Transforming growth factor-beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 110:576–582.
Lee MS, Gu D, Feng L et al. (1995) Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol 147:42–52.
Smith FE, Reitz P, Schuppin GT, Bonner-Weir S (1993) Transforming growth factor-/? is involved in regulation of rat pancreatic regeneration following 90% pancreatectomy. Pancreas 8:773 (abstract).
Bisgaard HC, Thorgeirsson SS (1991) Evidence for a common cell of origin for primitive epithelial cells isolated from rat liver and pancreas. J Cell Physiol 147:333–343.
Van Laethem JL, Deviere J, Resibois A et al. (1995) Localization of transforming growth factor-beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology 108:1873–1881.
Bockman DE, Merlino G (1992) Cytological changes in the pancreas of transgenic mice over-expressing transforming growth factor-a. Gastroenterology 103:1883–1892.
Lucas PA, Caplan Al (1988) Chemotactic response of embryonic limb bud mesenchymal cells and muscle derived fibroblasts to transforming growth factor-beta. Connect Tissue Res 18:1–7.
Makela TP et al. (1987) Regulation of platelet-derived growth factor gene expression by transforming growth factor-beta and phorbol ester in human leukaemia cell lines. Mol Cell Biol 7:3656–3662.
Battegay EJ et al. (1990) TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515–524.
Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48:193.
Todaro G, Fryling C, De Larco JE (1980) Transforming growth factors produced by certain human tumour cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci USA 77:5258–5262.
Friess H, Yamanaka Y, Buchler M, Kobrin MS, Tahara E, Korc M (1994) Cripto, a member of the epidermal growth factor family is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 56:668–674.
Korc M, Friess H, Yamanaka Y, Kobrin MS, Buchler M, Beger HG (1994) Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor-alpha and phospholipase C gamma. Gut 35:1468–1473.
Barton CM, Hall PA, Hughes CM, Gulli WJ, Lemoine NR (1991) Transforming growth factor-alpha and epidermal growth factor in human pancreatic cancer. J Pathol 163:111–116.
Tomioka T, Toshkov I, Kazakoff K et al. (1995) Cellular and subcellular localisation of transforming growth factor alpha and epidermal growth factor-receptor in normal and diseased human and hamster pancreas. Terat Carcinog Mutagen 15:231–250.
Arnush M, Gu D, Baugh C et al. (1996) Growth factors in the regenerating pancreas of c-interferon transgenic mice. Lab Invest 74:985–990.
Dinarello CA (1988) Interleukin-1. Dig Dis Sci 33:25S-35S.
Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK (1986) There is more than one interleukin-1. Immunol Today 7:45–56.
Gery I, Gershon RK, Waksman BH (1972) Potentiation of the T lymphocyte reponse to mitogens I. The responding cell. J Exp Med 136:128–142.
Durum SK, Schimdt JA, Oppenheim JJ (1985) Interluekin-1: an immunological perspective. Annu Rev Immunol 3:263–287.
Basso D, Plebeni M, Fogar P et al. (1995) Insulin-like growth factor, interleukin-1 alpha and beta in pancreatic cancer: role in tumour invasiveness and associated diabetes. Int J Clin Lab Res 25:40–43.
Bamba T, Yoshioka U, Inoue H, Iwasaki Y, Hosoda S (1994) Serum levels of interleukin-1 beta and interleukin-6 in patients with chronic pancreatitis. J Gastroenterol 29:314–319.
Cavalis E (1986) Interleukin-1 has independent effects on DNA and collagen synthesis in cultures of rat calvariae. Endocrinology 118:74–81.
Smith KA (1988) Interleukin-2: inception, impact and implications. Science 240:1169.
Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007–1008.
Ortaldo JR, Mason A, Gerard JP et al. (1984) Effects of natural and recombinant interleukin-2 on regulation of interferon-c production and natural killer cell activity: lack of involvement of the Tac antigen from these immunoregulatory effects. J Immunol 133:779–783.
Farrar JJ, Benjamin WR, Hifiker ML, Howard M, Farrar WL, Fuller-Farrar J (1982) The biochemistry, biology and role of IL-2 in the induction of cytotoxic T cell and antigen-forming B cell responses. Immunol Rev 63:129–166.
Inaba Kl, Grannelli-Piperno A, Steinman RM (1983) Dendritic cells induce T lymphocytes to release B cell stimulating factors by an IL-2 dependent mechanism. J Exp Med 158:2040–2057.
Pezzilli R, Billi P, Beltrandi E et al. (1994) Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis. Ital J Gastroenterol 26:137–140.
Rabbitti PG, Pacelli L, Uomo G et al. (1994) Soluble interleukin-2 receptor; a new marker in pancreatic adenocarcinoma? Minerva Gastroenterol Dietol 40:101–103.
Billau A (1987) Interferon /32 as a promoter of growth and differentiation of B cells. Immunol Today 8:84–87.
Gauldie J, Richards C, Harnish D, Lansdrop P, Baumann H (1987) Interferon beta-2/B cell stimulating factor type 2 shares identity with monocyte derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7521–7525.
Van Snick J (1990) IL-6: an overview. Annu Rev Immunol 8:253–278.
Campbell IL, Hobbs MV, Dockter J, Oldstone MB, Allison J (1994) Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol 145:157–166.
Sandor S, Zsuzsa S (1996) Basic fibroblast growth factor and PDGF in GI diseases. In: Goodland RA, Wright NA (eds) Bailliere’s clinical gastroenterology, 10:7. Saunders, London, pp 97–112.
Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1987) Structural characterisation and biological functions of fibroblast growth factor. Endocrine Rev 8:95–114.
Neufeld G, Gospodarowicz D (1986) Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J Biol Chem 261:5631–5637.
Folkmann I, Klagsbrunn M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I (1988) A heparin-binding angiogenic protein - fibroblast growth factor - is stored within basement membrane. Am J Pathol 130:393–400.
Friess H, Yamanaka Y, Buchler M, Beger HG, Do DA, Kobrin MS, Korc M (1994) Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am Pathol 144:117–128.
Izumi T, Shimizu T (1995) Platelet-activating factor receptor: gene expression and signal transduction. Biochim Biophys Acta 1259:317–333.
Zhou W, Levine BA, Olson MS (1994) Lipid mediator production in acute and chronic pancreatitis in the rat. J Surg Res 56:37–44.
Zhou WG, Chao W, Levine BA, Olson MS (1990) Evidence for platelet activating factor as a late-phase mediator of chronic pancreatitis in the rat. Am J Pathol 137:1501–1508.
Van Deijnen JHM, Van Suylichem PTR, Wolters GHJ, Van Schilfgaarde R (1994) Distribution of collagens type I, type II and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res 277:115–121.
Uscanga L, Kennedy RH, Choux R, Deuget M, Grimaud J-A, Sarles H (1984) Immunolocalization of collagen types, laminin and fibronectin in normal human pancreas. Digestion 30:158–164.
Kennedy RH, Bockman DE, Uscanga L, Grimaud J-A, Sarles H (1987) Pancreatic extracellular matrix alterations in chronic pancreatitis. Pancreas 2:61–17.
Panayotou G, End P, Aumailley M et al. (1989) Domains of laminin with growth factor activity. Cell 48:989–996.
Schuppan D, Somasundaram R, Just M (1992) The extracellular matrix: a major signal transduction network. In: Clement B Guillouzo A (eds) Cellular and molecular aspects of cirrhosis. Colloque INSERM/John Libbey Eurotext, London, pp 115–134.
Bissell DM (1992) Effects of extracellular matrix on hepatocyte behaviour. In: Clement B Guillouzo A (eds) Cellular and molecular aspects of cirrhosis. Colloque INSERM/John Libbey Eurotext, London, pp 187–197.
Border WA, Noble NA, Yamamoto T et al. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361–364.
Fowlkes JL, Suzuki K, Nagase H, Thrailkill KM (1994) Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: a role for matrix metalloproteinases. Endocrinology 135:2810–2813.
Arthur MJP, Iredale JP (1994) Hepatic lipocytes, TIMP-1 and liver fibrosis. J R Coll Phys Lond 28:200–208.
Nagase H, Barrett AJ, Woessner JF Jr (1992) Nomenclature and glossary of the matrix metallo-proteinases. Matrix (Suppl 1):421–424.
Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 6:121–125.
Murphy G, Hembry RM, Hughes CE, Fosang AJ, Hardingham TE (1990) Role and regulation of metalloproteinases in connective tissue turnover. Biochem Soc Trans 18:812–815.
Sato H, Takino T, Okada Y et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61–65.
Cao J, Sato H, Takino T, Seiki M (1995) The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase C activation. J Biol Chem 270:801–805.
Murphy G, Hembry RM (1992) Proteinases in rheumatoid arthritis. J Rheumatol 19:61–64.
Murphy G, Docherty AJP, Hembry RM, Reynolds JJ (1991) Metalloproteinases and tissue damage. Br J Rheumatol 30(Suppl 1):25–31.
Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y (1992) Progesterone regulates the activity of collagenase and related gelatinase-A and gelatinase-B in human endometrial explants. Proc Natl Acad Sci USA 89:11789–11793.
Overall CM, Wrana JL, Sudek J (1989) Independent regulation of collagenase, 72kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 264:1860–1869.
Edwards DR, Murphy G, Reynolds JJ et al. (1987) Transforming growth factor-beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899–1904.
Lafyatis R, Kim S-J, Angel P et al. (1990) Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5’ activator protein-1-binding site. Mol Endocrinol 4:973–980.
Wahl LM, Wahl SM, Mergenhagen SE, Martin GR (1974) Collagenase production by endotoxin - activated macrophages. Proc Natl Acad Sci USA 71:3598–3601.
Cury JD, Campbell EJ, Lazarus CJ, Albin RJ, Welgus HG (1988) Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts. J Immunol 141:4306–4312.
Wahl LM, Wahl SM, Mergenhagen SE, Martin GR (1975) Collagenase production by lymphokine-activated macrophages. Science 187:261–263.
Shapiro SD, Campbell EJ, Kobayashi DK (1990) Immune modulation of metalloproteinase production in human macrophages. J Clin Invest 86:1204–1210.
Bhatnagar R, Schade U, Rietschel ET, Decker K (1982) Involvement of prostaglandin E and adenosine 3 ’5’-monophosphate in lipopolysaccharide-stimulated collagenase release by rat Kupffer cells. Eur J Biochem 124:125–130.
McCarthy JB, Wahl SM, Rees JC, Olsen CE, Sandberg AL, Wahl LM (1980) Mediation of macrophage collagenase production by 3’-5’cyclic adenosine monophosphate. J Immunol 124:2405.
Wahl LM, Olsen CE, Sandberg AL, Mergenhagen SE (1977) Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci USA 74:4955–4958.
Wahl LM, Winter CC (1984) Regulation of guinea pig macrophage collagenase production by dexamethasone and colchicine. Arch Biochem Biophys 230:661–667.
Werb Z, Foley R, Munck A (1978) Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage line. J Immunol 121:115–121.
Murphy G, Docherty AJP (1992) The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 7:120–125.
Murphy G, Atkinson S, Ward R, Gavrilovic JJ, Reynolds JJ (1992) The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 667:1–12.
Edwards DR, Murphy G Reynolds JJ et al. (1987) Transforming growth factor-beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899–1904.
Stetler-Stevenson WG, Brown PD, Onisto M et al. (1990) Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumour cells and human tumour tissues. J Biol Chem 265:13933–13938.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag London Limited
About this chapter
Cite this chapter
Vyas, S.K. (1999). Growth Factors and Cytokines in Chronic Pancreatitis. In: Johnson, C.D., Imrie, C.W. (eds) Pancreatic Disease. Springer, London. https://doi.org/10.1007/978-1-4471-0801-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0801-6_16
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1205-1
Online ISBN: 978-1-4471-0801-6
eBook Packages: Springer Book Archive